Obesity Trial, Recruiting (NCT01129297)

Obesity Trial, Recruiting NCT01129297 Sponsor: University Hospital, Lille Condition: Obesity

Printed from Voxsanity (voxsanity.com.au) — NCT01129297 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Obesity

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You are between 18 and 65 years old
You are scheduled for abdominal surgery, either open surgery (laparotomy) or keyhole surgery (laparoscopy), for weight-loss surgery, gallbladder removal, or abdominal wall repair
You have a Body Mass Index (BMI) of 35 or above AND have been diagnosed with diabetes based on blood sugar test results
You have a BMI of 35 or above AND have blood sugar levels that are higher than normal but not yet at diabetes level (sometimes called "pre-diabetes")
You have a BMI of 35 or above AND have normal blood sugar levels with no diabetes
You have a BMI below 27 AND have normal blood sugar levels with no diabetes
You have a BMI between 27 and 35 AND have normal blood sugar levels with no diabetes

Who may not be able to join:

You are not able to understand and receive clear information about the trial (confirm with trial site)
You do not wish to sign the consent form agreeing to take part
You have an additional health condition that, in the surgeon's opinion, could increase the risk of complications from having a tissue sample taken during surgery

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 23 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT01129297

Sponsor: University Hospital, Lille

Phase: Not Applicable

Status: Recruiting

Condition: Obesity

More information: https://clinicaltrials.gov/study/NCT01129297

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You are between 18 and 65 years old
You are scheduled for abdominal surgery, either open surgery (laparotomy) or keyhole surgery (laparoscopy), for weight-loss surgery, gallbladder removal, or abdominal wall repair
You have a Body Mass Index (BMI) of 35 or above AND have been diagnosed with diabetes based on blood sugar test results
You have a BMI of 35 or above AND have blood sugar levels that are higher than normal but not yet at diabetes level (sometimes called "pre-diabetes")
You have a BMI of 35 or above AND have normal blood sugar levels with no diabetes
You have a BMI below 27 AND have normal blood sugar levels with no diabetes
You have a BMI between 27 and 35 AND have normal blood sugar levels with no diabetes

Who may not be able to join:

You are not able to understand and receive clear information about the trial (confirm with trial site)
You do not wish to sign the consent form agreeing to take part
You have an additional health condition that, in the surgeon's opinion, could increase the risk of complications from having a tissue sample taken during surgery

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 23 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

University Hospital, Lille

Registry

ClinicalTrials.gov

Start date

13 June 2006

Est. completion

1 June 2027

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Study the influence of phenotypic characteristics on gene expression of tissues involved in glucose metabolism

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov